Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.2235 EUR | -2.83% | -6.29% | +11.97% |
04-17 | SpineGuard SA Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | SpineGuard SA announced that it expects to receive ?1.998 million in funding | CI |
Valuation
Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Capitalization 1 | 18.71 | 5.146 | 1.948 | 23.23 | 33.69 | 18.41 |
Enterprise Value (EV) 1 | 23.81 | 10.42 | 6.745 | 27.79 | 33.28 | 18.34 |
P/E ratio | -4.45 x | -2.08 x | -3.28 x | -9.29 x | -18 x | -7.26 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 2.29 x | 0.68 x | 0.29 x | 4.79 x | 7.65 x | 3.29 x |
EV / Revenue | 2.91 x | 1.38 x | 0.99 x | 5.73 x | 7.56 x | 3.27 x |
EV / EBITDA | -9.86 x | -10.9 x | -32.7 x | -33.2 x | -29.7 x | -12.9 x |
EV / FCF | -17.8 x | -10.6 x | -19.7 x | 493 x | -36.8 x | -12.3 x |
FCF Yield | -5.61% | -9.45% | -5.08% | 0.2% | -2.72% | -8.14% |
Price to Book | -91.7 x | -10.7 x | 5.29 x | -3,421 x | 6.67 x | 3.75 x |
Nbr of stocks (in thousands) | 5,584 | 6,700 | 8,049 | 17,867 | 29,710 | 31,714 |
Reference price 2 | 3.350 | 0.7680 | 0.2420 | 1.300 | 1.134 | 0.5805 |
Announcement Date | 18-03-15 | 19-03-15 | 20-03-20 | 21-04-28 | 22-04-29 | 23-04-18 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Net sales 1 | 8.174 | 7.575 | 6.829 | 4.852 | 4.405 | 5.6 |
EBITDA 1 | -2.414 | -0.9594 | -0.2065 | -0.836 | -1.119 | -1.418 |
EBIT 1 | -2.547 | -1.073 | -0.3114 | -0.961 | -1.239 | -1.526 |
Operating Margin | -31.15% | -14.16% | -4.56% | -19.81% | -28.12% | -27.26% |
Earnings before Tax (EBT) 1 | -4.125 | -2.315 | -1.075 | -2.68 | -1.649 | -2.089 |
Net income 1 | -4.125 | -2.334 | -0.6857 | -2.716 | -1.725 | -2.393 |
Net margin | -50.47% | -30.81% | -10.04% | -55.99% | -39.15% | -42.74% |
EPS 2 | -0.7525 | -0.3700 | -0.0737 | -0.1400 | -0.0631 | -0.0800 |
Free Cash Flow 1 | -1.336 | -0.984 | -0.3427 | 0.0564 | -0.9044 | -1.492 |
FCF margin | -16.34% | -12.99% | -5.02% | 1.16% | -20.53% | -26.65% |
FCF Conversion (EBITDA) | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 18-03-15 | 19-03-15 | 20-03-20 | 21-04-28 | 22-04-29 | 23-04-18 |
Balance Sheet Analysis
Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Net Debt 1 | 5.1 | 5.27 | 4.8 | 4.56 | - | - |
Net Cash position 1 | - | - | - | - | 0.41 | 0.07 |
Leverage (Debt/EBITDA) | -2.113 x | -5.495 x | -23.23 x | -5.459 x | - | - |
Free Cash Flow 1 | -1.34 | -0.98 | -0.34 | 0.06 | -0.9 | -1.49 |
ROE (net income / shareholders' equity) | -841% | 669% | -1,338% | -932% | -68.4% | -47% |
ROA (Net income/ Total Assets) | -18.1% | -8.38% | -2.38% | -7.26% | -7.76% | -8.15% |
Assets 1 | 22.76 | 27.87 | 28.81 | 37.44 | 22.23 | 29.36 |
Book Value Per Share 2 | -0.0400 | -0.0700 | 0.0500 | -0 | 0.1700 | 0.1500 |
Cash Flow per Share 2 | 0.2100 | 0.1600 | 0.1100 | 0.0500 | 0.1800 | 0.1200 |
Capex 1 | 0.04 | 0.05 | 0.08 | 0.05 | 0.04 | 0.03 |
Capex / Sales | 0.52% | 0.63% | 1.13% | 1% | 0.87% | 0.61% |
Announcement Date | 18-03-15 | 19-03-15 | 20-03-20 | 21-04-28 | 22-04-29 | 23-04-18 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
+11.97% | 11.32M | |
+73.17% | 12.38B | |
-18.74% | 7.92B | |
+16.15% | 7.2B | |
+4.81% | 5.84B | |
+5.99% | 5.01B | |
+27.07% | 4.53B | |
-21.67% | 3.88B | |
-40.82% | 2.23B | |
+1.49% | 2.02B |
- Stock Market
- Equities
- ALSGD Stock
- Financials SpineGuard